GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year Core EBITDA Margin History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Core EBITDA Margin(%) | 12.37 | 15.67 |
What is the latest Core EBITDA Margin ratio of GUFIC BIOSCIENCES ?
| Year | Core EBITDA Margin |
|---|---|
| Mar2025 | 12.37 |
| Mar2024 | 15.67 |
How is Core EBITDA Margin of GUFIC BIOSCIENCES Trending?
| Years | Core EBITDA Margin | % Change | |
|---|---|---|---|
| Mar2025 | 12.37 | -21.06 | |
| Mar2024 | 15.67 | - | |
Other Financial Ratios of GUFIC BIOSCIENCES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Margin ratio of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹2,996.0 Cr | 3.1% | 7% | -9.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,050.0 Cr | 1.3% | -4.5% | -0% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,157.0 Cr | 1.7% | -5.9% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,531.0 Cr | 2.6% | -5% | 25.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,190.0 Cr | -0.4% | -7% | 3.6% | Stock Analytics | |
| CIPLA | ₹98,892.8 Cr | 2.6% | -7.4% | -16.3% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | 3.1% |
7% |
-9.7% |
| SENSEX | 4.8% |
-4.2% |
0.8% |
You may also like the below Video Courses